Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

21.45 -0.20 (-0.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Schrödinger Reports Second Quarter 2023 Financial Results
From Schrödinger, Inc.
Via Business Wire
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users. 
Via MarketBeat
Topics Artificial Intelligence
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges. 
Via MarketBeat
Topics Artificial Intelligence
Exscientia is the Sniper of the AI Drug Discovery Industry
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion 
Via MarketBeat
Topics Artificial Intelligence
Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna
Via Benzinga
3 Cutting-Edge Biotech Stocks That Are Riding the AI Wave Like None Other
They're not guaranteed to keep soaring, but they are right now. 
Via The Motley Fool
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrödinger to Announce Second Quarter 2023 Financial Results on August 2
From Schrödinger, Inc.
Via Business Wire
Better AI Biotech Stock: Schrödinger vs. Recursion Pharmaceuticals
Both companies could tap into huge growth from the AI revolution in a few years. 
Via The Motley Fool
This Artificial Intelligence Biotech Stock Is Crushing the Market, but Is It a Buy?
Its software platform could become a core tool for many businesses in biopharma. 
Via The Motley Fool
Nvidia Invested $50 million into This AI Drug Discovery Biotech
Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from 
Via MarketBeat
Topics Artificial Intelligence
Cathie Wood's Ark Invest Makes Major Quantum-Si Purchase — Loads Up On 1.4M Shares Of Semiconductor Firm
Via Benzinga
Stocks Pulsate As June Inflation Undercuts Expectations: 10 Major Reactions
Via Benzinga
Trump Advisor Says Ex-President May Skip Initial Republican Presidential Primary Debates
Via Benzinga
Why These 3 Stocks Are the Best Ways to Play AI Right Now
These three AI stocks are growing rapidly, and their stock prices are a very long way from reflecting their true, tremendous potential. 
Via InvestorPlace
The 3 Best Sectors to Invest in for July 2023
The best sectors for investors are those getting boosts from two strong trends: the electrification of transportation and AI. 
Via InvestorPlace
Schrödinger To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
Keybanc boosted the price target for Micron Technology, Inc. (NASDAQ: MU) from $70 to $80. Keybanc analyst John Vinh maintained an Overweight rating. Micron shares rose 3.9% to $69.70 in pre-market... 
Via Benzinga
ETF Returns: Mid-Cap Winners And Losers
We performed a screening of mid-cap ETFs - defined as having Assets Under Management (AUM) between $2 billion and $10 billion - to determine what funds had the largest positive and negative returns on... 
Via Benzinga
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
7 Stocks in Hot Water: Dump This Dead Weight as Costs Skyrocket
While an uncomfortable topic that arouses a range of emotions, investors must grapple with overvalued stocks to sell. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 AI Stocks That Could Skyrocket Your Wealth
AI is poised to greatly increase the top and bottom lines of many companies, making many AI stocks very attractive at this point. 
Via InvestorPlace
Why Shares of Schrödinger Rose This Week
Interest in the company's AI platform continues to drive the stock. 
Via The Motley Fool
Gambling.com, Editas Medicine And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
3 Revolutionary Companies With Trillion-Dollar Potential
These are just a few of the trillion-dollar potential companies to put on your radar screen for the second half. 
Via InvestorPlace
Palo Alto Networks Shares Surge As It Joins S&amp;P 500: Who Is It Replacing?
Via Benzinga
Palo Alto Networks To Join S&P 500 Index: Here Are All The S&P Index Changes
Here are the changes to the S&P indexes before the open on June 20. 
Via Investor's Business Daily
Schrödinger to Present at Goldman Sachs 44th Annual Global Healthcare Conference
From Schrödinger
Via Business Wire
3 Pharma Stocks That Will Boom Thanks to AI
Some pharma stocks to buy are benefiting from AI, but perhaps none more than these 3 that have developed deep platforms. 
Via InvestorPlace
Schrödinger to Present at Jefferies Global Biopharma Conference
From Schrödinger
Via Business Wire
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.